Tag: Business

Discussion with CEOs from Inspirata and Omnyx

| February 14, 2018 | 0 Comments

In the wake of the news of Inspirata acquiring Omnyx recently I had an opportunity to speak with the CEOs of each company and get their thoughts. The big question in my mind and those of many readers was “Why Omnyx? Why now?” How did this happen? Below is a summary of our discussion. Perhaps […]

Continue Reading

Paige.AI Lands $25 Million Series A Financing and 25 Million Slides from Memorial Sloan Kettering

| February 8, 2018 | 0 Comments

25 million slides in an exclusive relationship with MSK and 25 million dollars in funding are some big numbers.  Paige.AI, a new company focused on revolutionizing clinical diagnosis and treatment in oncology through use of artificial intelligence (AI), recently announced two major milestones: Paige.AI signed a comprehensive license agreement with Memorial Sloan Kettering Cancer Center (MSK) to gain […]

Continue Reading

Changes Coming at Omnyx – Developing Story

| July 19, 2016 | 0 Comments

Nearly 10 years ago GE Healthcare and the University of Pittsburgh Medical Center (UPMC)entered into a joint venture. The two organizations began a two year collaboration process and founded the company in 2008. Since that time, close collaboration brought to market new innovations in digital pathology, culminating in Dynamyx (TM), which was demonstrated at USCAP this […]

Continue Reading

Farewell PathologyBlawg.com

| November 26, 2015 | 0 Comments

Blogs, like blog readers, come and go.  It is part of the nature of creating blogs and reading blogs. Writing a blog consumes resources for the blogger and readers take time to read and comment or share on what one writes if it strikes a chord with them. We all try in the blogosphere to […]

Continue Reading

NeoGenomics to Pay $275M for Clarient

| October 22, 2015 | 0 Comments

More on this recent news to follow on thoughts about implications for pathology market as a whole and digital pathology (including GE-Omnyx).  GE paid $587 million for Clarient in an announcement 5 years ago today. NeoGenomics, a biotech company specializing in genomic cancer diagnostics, has announced the acquisition of Clarient, a unit of General Electric […]

Continue Reading

New Webinar: Moving from Volume-Based to Value-Based: New Business Models in the Clinical Laboratory Industry

| September 2, 2015 | 0 Comments

Is it time for your lab to have a strategy for delivering value in ways that increase reimbursement for your lab testing services? Answer “YES” to that question and you’ll want to join us for this special webinar event! Join us Tuesday, September 22 at 1 PM EDT! REGISTER YOUR TEAM!  Your Presenters: Richard J. Cote, M.D., […]

Continue Reading

Making Clinical Diagnosis Picture-Perfect the Focus at Huron Digital Pathology

| February 16, 2015 | 0 Comments

Readers may have noticed recently Huron Digital Pathology has rebranded itself from Huron Technologies and Biomedical Photometrics prior to that.  Their new logo on the right sidebar reflects their continued focus on manufacturing reliable scanning technologies within digital pathology.  More company history and news is contained in the press release below.  Check out their revamped website […]

Continue Reading